Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe! TODAY’S NEWS P&G's drug unit to be snapped up, by... - Warner …
Today’s Top Three in Pharma 042309
FDA extends review of AstraZeneca/BMS experimental diabetes drug Onglyza. Teva blocked from launching generic form of Lilly's Evista; also rumored to be eyeballing a purchase of …
Today’s Top Three in Pharma 030409
Teva's Copaxone approved for preventative treament of MS - The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become …
Today’s Top Three in Pharma 021909
Teva aggressively seeking to "genericize" Merck's Singulair, Amgen's Neupogen. Warren Buffet pulling back from pharma investments that contain 2 letters (P&G, J&J). GSK's nausea drug Zofran …
Today’s Top Three in Pharma 020209
The FDA gives a hint of hope for the long-delayed Eli Lilly/Daiichi Sankyo drug prasugrel. Burrow deep inside this 357-page FDA document just posted online, and you’ll find this jargony but …
Today’s Top Three in Pharma 012109
Will the Feds soon decide on drugs based on cost/effectiveness calculations? “They claim that they don’t want this to morph into a British-style agency that restricts access to medical products based …